A detailed history of Credit Suisse Ag transactions in Glaukos Corp stock. As of the latest transaction made, Credit Suisse Ag holds 87,337 shares of GKOS stock, worth $11.4 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
87,337
Previous 85,367 2.31%
Holding current value
$11.4 Million
Previous $6.79 Million 21.37%
% of portfolio
0.01%
Previous 0.01%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$76.4 - $96.33 $150,508 - $189,770
1,970 Added 2.31%
87,337 $8.24 Million
Q4 2023

Feb 08, 2024

BUY
$59.53 - $85.11 $573,988 - $820,630
9,642 Added 12.73%
85,367 $6.79 Million
Q3 2023

Nov 13, 2023

SELL
$69.23 - $79.09 $152,790 - $174,551
-2,207 Reduced 2.83%
75,725 $5.7 Million
Q2 2023

Aug 11, 2023

BUY
$45.44 - $71.21 $143,272 - $224,525
3,153 Added 4.22%
77,932 $5.55 Million
Q1 2023

May 10, 2023

BUY
$43.88 - $52.48 $219,136 - $262,085
4,994 Added 7.16%
74,779 $3.75 Million
Q4 2022

Feb 13, 2023

BUY
$40.82 - $57.75 $541,109 - $765,534
13,256 Added 23.45%
69,785 $3.05 Million
Q3 2022

Nov 10, 2022

BUY
$46.84 - $58.49 $254,481 - $317,776
5,433 Added 10.63%
56,529 $3.01 Million
Q2 2022

Aug 12, 2022

SELL
$34.86 - $63.77 $58,251 - $106,559
-1,671 Reduced 3.17%
51,096 $2.32 Million
Q1 2022

May 16, 2022

BUY
$44.33 - $57.82 $304,813 - $397,570
6,876 Added 14.98%
52,767 $3.05 Million
Q4 2021

Feb 14, 2022

SELL
$40.27 - $56.99 $19,249 - $27,241
-478 Reduced 1.03%
45,891 $2.04 Million
Q3 2021

Nov 12, 2021

SELL
$47.43 - $84.23 $277,370 - $492,577
-5,848 Reduced 11.2%
46,369 $2.23 Million
Q2 2021

Aug 16, 2021

BUY
$73.06 - $97.7 $431,200 - $576,625
5,902 Added 12.74%
52,217 $4.29 Million
Q1 2021

May 14, 2021

SELL
$70.43 - $97.42 $653,872 - $904,447
-9,284 Reduced 16.7%
46,315 $3.89 Million
Q4 2020

Feb 12, 2021

BUY
$48.9 - $75.26 $887,486 - $1.37 Million
18,149 Added 48.46%
55,599 $4.18 Million
Q3 2020

Nov 13, 2020

SELL
$37.23 - $50.97 $368,465 - $504,450
-9,897 Reduced 20.9%
37,450 $1.86 Million
Q2 2020

Aug 12, 2020

BUY
$28.78 - $46.83 $297,498 - $484,081
10,337 Added 27.93%
47,347 $1.82 Million
Q1 2020

May 13, 2020

BUY
$25.53 - $70.14 $4,901 - $13,466
192 Added 0.52%
37,010 $1.14 Million
Q4 2019

Feb 12, 2020

BUY
$54.18 - $65.64 $590,345 - $715,213
10,896 Added 42.03%
36,818 $2.01 Million
Q3 2019

Nov 12, 2019

SELL
$58.58 - $83.91 $483,812 - $693,012
-8,259 Reduced 24.16%
25,922 $1.62 Million
Q2 2019

Aug 14, 2019

SELL
$63.59 - $78.71 $130,486 - $161,512
-2,052 Reduced 5.66%
34,181 $2.58 Million
Q1 2019

May 14, 2019

BUY
$50.75 - $80.54 $348,601 - $553,229
6,869 Added 23.39%
36,233 $2.84 Million
Q4 2018

Feb 13, 2019

BUY
$52.18 - $67.93 $181,951 - $236,871
3,487 Added 13.48%
29,364 $1.65 Million
Q3 2018

Nov 13, 2018

SELL
$38.13 - $68.37 $306,183 - $549,011
-8,030 Reduced 23.68%
25,877 $1.68 Million
Q2 2018

Aug 14, 2018

BUY
$27.62 - $44.51 $239,216 - $385,501
8,661 Added 34.31%
33,907 $1.38 Million
Q1 2018

May 15, 2018

SELL
$26.05 - $34.5 $3,933 - $5,209
-151 Reduced 0.59%
25,246 $778,000
Q4 2017

Feb 14, 2018

BUY
$24.5 - $36.01 $2,989 - $4,393
122 Added 0.48%
25,397 $651,000
Q3 2017

Nov 14, 2017

SELL
$31.26 - $42.03 $2.03 Million - $2.73 Million
-65,060 Reduced 72.02%
25,275 $834,000
Q2 2017

Aug 14, 2017

BUY
N/A
90,335
90,335 $3.75 Million

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $6.2B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Credit Suisse Ag Portfolio

Follow Credit Suisse Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.